How strong were AMETEK's fourth-quarter 2023 results?

Results were strong. Sales were a record $1.73 billion, up 6.5%, and operating income was a record $445.0 million, up 12%. Operating margin reached 25.7%, up 120 basis points. GAAP diluted EPS was $1.48 (versus $1.33), and adjusted diluted EPS was a record $1.68, up about 11% from the prior-year comparable level of $1.52.

What is driving the difference between GAAP and adjusted EPS?

Adjusted EPS adds back non-cash, after-tax amortization of acquisition-related intangibles. In Q4 2023 this was $0.20 per diluted share ($0.26 pretax less $0.06 tax benefit). For full-year 2023, the add-back was $0.71 per share ($0.93 pretax less $0.22 tax benefit), which explains the gap between GAAP EPS of $5.67 and adjusted EPS of $6.38. Because amortization stems from acquisitions, the gap is likely to persist as AMETEK continues to acquire businesses.

Did the Electromechanical Group perform as well as the Electronic Instruments Group?

Not quite. EIG delivered record Q4 operating income of $359.0 million, up 17%, and a 29.0% margin. EMG's Q4 sales rose 6% to $494.7 million, but its operating income fell to $112.3 million from $114.5 million, with margin at 22.7%. Management highlighted aerospace and defense growth and core margin expansion at EMG, but the reported operating income decline is a point investors may want to examine further.

What is the company's 2024 outlook?

Management expects overall 2024 sales to grow at a low double-digit percentage rate versus 2023, and adjusted diluted EPS of $6.70 to $6.85, up 5% to 7%. For Q1 2024, it expects low double-digit sales growth and adjusted EPS of $1.56 to $1.60, up 5% to 7%. The implied GAAP EPS guidance for FY2024 is $5.88 to $6.03.

Has AMETEK's balance sheet changed meaningfully?

Yes. Total debt is roughly $3.3 billion, with short-term borrowings and current debt of $1.42 billion, up from $226 million a year earlier, and long-term debt of $1.90 billion, down from $2.16 billion. Cash was $410 million, implying net debt of about $2.9 billion. Goodwill and intangibles grew significantly with acquisitions, and total assets rose to $15.0 billion from $12.4 billion. Management says it retains a flexible balance sheet and strong cash flows to fund both organic investment and acquisitions, but the increase in current debt warrants monitoring for refinancing needs.

AME 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed February 6, 2024. Cited figures are marked; the original filing is the authoritative source.

AMETEK (NYSE: AME) reported record fourth-quarter and full-year 2023 results, furnished under Item 2.02 of Form 8-K.

Q4 2023 net sales rose 6.5% year over year to a record $1.73 billion^a, and operating income rose 12% to a record $445.0 million, with operating margin up 120 basis points to 25.7%. GAAP diluted EPS was $1.48 (up from $1.33), and adjusted diluted EPS was a record $1.68, up about 11% from the prior-year comparable figure. For the full year, sales grew 7% to a record $6.60 billion, operating income rose 14% to $1.71 billion, and adjusted EPS of $6.38 rose 12% from $5.68.

Operating cash flow in Q4 was a record $540.7 million^b, up 40%. Management attributed the results to organic growth, recent acquisitions, and operating improvements, and said it deployed about $2.25 billion on acquisitions in 2023, including Paragon Medical. The Electronic Instruments Group (EIG) drove most of the performance, with Q4 sales of $1.24 billion (up 7%) and operating margin of 29.0% (up 250 basis points).

The Electromechanical Group (EMG) posted Q4 sales of $494.7 million^c (up 6%), though its operating income declined year over year to $112.3 million from $114.5 million, with margin at 22.7%. The balance sheet shows a material increase in leverage: goodwill rose to $6.45 billion from $5.37 billion, and short-term borrowings and current debt jumped to $1.42 billion from $226 million, while long-term debt fell to $1.90 billion from $2.16 billion. Total debt is roughly $3.3 billion against $410 million of cash, so net debt is about $2.9 billion.

For 2024, management guided to overall sales growth of low double digits in percentage terms and adjusted diluted EPS of $6.70 to $6.85^d, an increase of 5% to 7%. For Q1 2024, guidance calls for low double-digit sales growth and adjusted EPS of $1.56 to $1.60, up 5% to 7%. The release does not provide a GAAP-to-adjusted bridge beyond amortization of acquisition-related intangibles, and the guidance reflects management's expectations, which are subject to the risks listed in the forward-looking statements.

02—Key points

Key Highlights

Record Q4 2023 sales of $1.73 billion (+6.5% YoY) and record operating income of $445.0 million (+12% YoY), with operating margin of 25.7%, up 120 bps.
Full-year 2023 sales reached a record $6.60 billion (+7%), operating income reached $1.71 billion (+14%), and operating margin expanded 150 bps to 25.9%.
Adjusted diluted EPS was a record $1.68 in Q4 and $6.38 for FY2023 (+12%); GAAP diluted EPS was $1.48 in Q4 and $5.67 for FY2023.
Q4 operating cash flow was a record $540.7 million, up 40% YoY.
EIG was the standout segment, with Q4 operating margin of 29.0% (+250 bps) and operating income up 17% to a record $359.0 million; EMG operating income declined to $112.3 million from $114.5 million.
Approximately $2.25 billion was deployed on acquisitions in 2023, including Paragon Medical, and goodwill increased to $6.45 billion from $5.37 billion.
2024 guidance calls for low double-digit sales growth and adjusted EPS of $6.70 to $6.85 (+5% to 7%); Q1 2024 adjusted EPS guidance is $1.56 to $1.60.

03—Questions

Frequently Asked Questions

How strong were AMETEK's fourth-quarter 2023 results?
Results were strong. Sales were a record $1.73 billion, up 6.5%, and operating income was a record $445.0 million, up 12%. Operating margin reached 25.7%, up 120 basis points. GAAP diluted EPS was $1.48 (versus $1.33), and adjusted diluted EPS was a record $1.68, up about 11% from the prior-year comparable level of $1.52.
What is driving the difference between GAAP and adjusted EPS?
Adjusted EPS adds back non-cash, after-tax amortization of acquisition-related intangibles. In Q4 2023 this was $0.20 per diluted share ($0.26 pretax less $0.06 tax benefit). For full-year 2023, the add-back was $0.71 per share ($0.93 pretax less $0.22 tax benefit), which explains the gap between GAAP EPS of $5.67 and adjusted EPS of $6.38. Because amortization stems from acquisitions, the gap is likely to persist as AMETEK continues to acquire businesses.
Did the Electromechanical Group perform as well as the Electronic Instruments Group?
Not quite. EIG delivered record Q4 operating income of $359.0 million, up 17%, and a 29.0% margin. EMG's Q4 sales rose 6% to $494.7 million, but its operating income fell to $112.3 million from $114.5 million, with margin at 22.7%. Management highlighted aerospace and defense growth and core margin expansion at EMG, but the reported operating income decline is a point investors may want to examine further.
What is the company's 2024 outlook?
Management expects overall 2024 sales to grow at a low double-digit percentage rate versus 2023, and adjusted diluted EPS of $6.70 to $6.85, up 5% to 7%. For Q1 2024, it expects low double-digit sales growth and adjusted EPS of $1.56 to $1.60, up 5% to 7%. The implied GAAP EPS guidance for FY2024 is $5.88 to $6.03.
Has AMETEK's balance sheet changed meaningfully?
Yes. Total debt is roughly $3.3 billion, with short-term borrowings and current debt of $1.42 billion, up from $226 million a year earlier, and long-term debt of $1.90 billion, down from $2.16 billion. Cash was $410 million, implying net debt of about $2.9 billion. Goodwill and intangibles grew significantly with acquisitions, and total assets rose to $15.0 billion from $12.4 billion. Management says it retains a flexible balance sheet and strong cash flows to fund both organic investment and acquisitions, but the increase in current debt warrants monitoring for refinancing needs.

04—Continue

← View all 8-K filings